Table 2.
Overview of Studies Addressing PS in Schizophrenia
| Study | Sample (n) | Mean Age | Inpatient/Outpatient | Medication | Psychomotor Task | Main Findings |
| Caligiuri et al120 | Neuroleptic-naive schizophrenic patients (24) | 42.2 | 14 inpatients and 10 outpatients | / | Wrist rotation | 12% of neuroleptic-naive schizophrenic patients had bradykinesia compared with none of the healthy controls. |
| Healthy controls (24) | 42.2 | |||||
| Carnahan et al121 | Schizophrenics (12) | 29.3 | ? | Antipsychotics | Fitts' task with mouse on graphics tablet | Relative to the healthy controls, the patients exhibited a movement-planning deficit without a decrement in movement execution. The patients still performed according to Fitts' law, which states that in aiming movement time decreases as target distance decreases and target size increases. |
| Healthy controls (12) | 26.1 | |||||
| Fuller and Jahanshahi33 | Schizophrenics (11) | 38.5 | Outpatients | Antipsychotics | Purdue pegboard task and FTT | Patients were slower than the controls in both tasks in the unimanual but not in the bimanual condition. Peg placing was less slowed when performing a secondary task with the other hand. Pegboard and FTT performance significantly correlated with negative symptoms. |
| Controls (13) | 38.15 | |||||
| Gallucci et al122 | Schizophrenics (20) | 31.1 | ? | 2 unmedicated, 12 AAP, 6 CNL, and 4 anticholinergics | Handwriting movements recorded with graphics tablet | Handwriting in patients was not slowed but less efficient and consistent with a trend toward macrographic strokes. |
| Matched controls | ||||||
| Henkel et al35 | Schizophrenics (16) | 35.1 | Inpatients | Test-retest: drug-free vs haloperidol (mean dose: 10.4 mg) and anticholinergics (n = 6) | Drawing of circles and writing of sentences on writing tablet | Performance of neuroleptic-free patients was slower. Slowing was associated with negative symptoms. Amelioration of negative symptoms under haloperidol treatment was significantly associated with speeding-up of handwriting. |
| Healthy controls (16) | ||||||
| Holthausen et al54 | Schizophrenics (32) | 24.8 | ? | Average dose: 6.1 mg haloperidol equivalents, 7 drug-free patients, and 15 on anticholinergics | FTT | FTT correlated with the depressive and the negative symptom dimension. |
| Schizophreniform (10) | 23.7 | |||||
| Delusional disorder (2) | 28.5 | |||||
| Brief psychotic disorder (2) | 18.0 | |||||
| Psychotic disorder NOS (4) | 31.8 | |||||
| Jogems-Kosterman et al38 | Schizophrenia (19) | 37.0 | 14 outpatients | Antipsychotics (mean dosage 7.6 mg haloperidol equivalents) | Line-copying task, complex-figure copying task recorded on writing tablet | Patients' movement initiation and execution was slowed. Overall, patients were one-third slower than the controls. Initiation time latencies with increasing complexity were significantly higher in the subgroup with higher negative symptoms. Increased reinspection times demonstrated affected planning strategy. |
| Controls (19) | 37.5 | |||||
| Malla et al36 | Schizophrenics (21) | 29.0 | ? | Antipsychotics | Fitts' task with mouse on graphics tablet | Weak correlations between psychomotor poverty and RTs and no correlations with movement times. Strong associations between RT and disorganization syndrome. |
| Mohamed et al123 | First-episode schizophrenics (94) | 26.1 | Inclusion after admission | 73 neuroleptic-naive patients, 14 receiving antipsychotics for less than a week, 7 for less than 2 wk | FTT | Impairments in speeded cognitive tasks with (SDST, and TMT) and without (Stroop) motor component. Patients performed relatively better on the FTT, leading the authors to conclude that poor performance on speeded tasks reflects bradyphrenia rather than bradykinesia. |
| Normal controls (305) | 25.5 | |||||
| Morrens et al39 | Schizophrenics (30) | 27.5 | Inpatients | Atypical antipsychotics (22), conventional neuroleptics (7), and other psychotropics | SDST on graphics tablet | Both matching time (initiation) and writing time (execution) on SDST were slowed but unassociated. Matching time, reflecting slowing in higher order cognitive processes, but not writing time, reflecting PS, proved associated with other neuropsychological measures. |
| Controls (30) | 33.0 | |||||
| Putzhammer et al41 | Drug-naive schizophrenic patients (25) | / | ? | In addition: 14 patients lorazepam and 12 patients biperiden | Movement analysis of gait | Relative to the healthy controls, all patients exhibited decreased gait velocity due to shorter stride length while cadence (steps per minute) was not affected. Conventional antipsychotics intensified the problem, whereas atypicals did not cause additional gait disturbances. |
| Schizophrenic patients treated with CNL (16) | ||||||
| Schizophrenic patients treated with AAP (25) | ||||||
| Healthy controls (25) | ||||||
| Putzhammer et al44 | Drug-naive schizophrenic patients (14) | 36 | Inpatients | In addition: 8 patients in total lorazepam and 5 patients in total biperiden | Movement analysis of gait | Compared with the healthy controls, all patients had decreased gait velocity due to shorter stride length. The most striking difference was observed between the patients on CNL and the controls. Impaired gait parameters can be normalized in schizophrenic patients by external stimulation via treadmill walking. |
| Schizophrenics treated with CNL (14) | 38 | |||||
| Schizophrenics treated with olanzapine (14) | 35 | |||||
| Healthy controls (14) | 46 | |||||
| Schroder et al124 | Schizophrenics (12) | 28 | ? | 9 clozapine, 2 conventionals+ biperiden, and 1 drug free | Pronation/supination device during fMRI | No differences in measures of motor retardation (repetition rate and amplitude) between patients and controls. Variability was significantly increased in the patients and activation of sensorimotor and SMA cortices was significantly decreased. |
| Healthy controls (12) | 27 | |||||
| Tigges et al125 | Schizophrenics (27) | 31.0 | Inpatients | 13 drug free and 14 CPZ-eq: 507 mg | Handwriting on writing tablet | Patients had longer stroke durations and decreased automatization. Stroke length and velocity were less regular in the treated patients. Stroke-length irregularity was higher in patients treated with atypicals and not with typicals. Positive and negative symptoms had little relation to the handwriting measures. |
| Healthy controls (31) | 33.3 | |||||
| Van Hoof et al37 | Schizophrenics (20) | 39.9 | Inpatients | CPZ-eq = 710 | SDST on a writing tablet | The depressed patients demonstrated an overall slowing in matching and writing times, whereas the schizophrenic patients only displayed prolonged matching times in comparison with both the depressed patients and the healthy controls. |
| Depressed patients (20) | 47.0 | |||||
| Healthy controls (20) | 43.1 | |||||
| Yang et al81 | Schizophrenics (28) | 29.3 | 19 outpatients and 9 other (?) | 19 neuroleptic treatment and 9 medication free | FTT | The FTT showed the strongest correlation with D2 receptor binding, while the WCST and attention test had no correlation with D2 receptor binding. |
Note: AAP = atypical antipsychotics, CNL = conventional neuroleptics, CPZ-eq = chlorpromazine equivalents, FTT = finger-tapping test, SDST = Symbol Digit Substitution test, SMA = supplementary motor area, TMT = Trailmaking Test, WCST = Wisconsin Card Sorting Test, RT = reaction time, PS = psychomotor slowing, and NOS = not otherwise specified.